STOCKHOLM--(BUSINESS WIRE)--Regulatory News: The prospectus regarding the admission to trading of newly issued shares in NeuroVive Pharmaceutical AB (publ) (STO:NVP) is now available on the company’s website www.neurovive.se and in the company’s offices, at Medicon Village, Scheelevägen 2, 223 81 Lund. Documents incorporated by reference in the prospectus are also available in accordance with the above.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
